204 related articles for article (PubMed ID: 27856419)
1. Neuropeptide Y (NPY) promotes inflammation-induced tumorigenesis by enhancing epithelial cell proliferation.
Jeppsson S; Srinivasan S; Chandrasekharan B
Am J Physiol Gastrointest Liver Physiol; 2017 Feb; 312(2):G103-G111. PubMed ID: 27856419
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-neuropeptide Y cross talk regulates inflammation, epithelial barrier functions, and colonic motility.
Chandrasekharan B; Jeppsson S; Pienkowski S; Belsham DD; Sitaraman SV; Merlin D; Kokkotou E; Nusrat A; Tansey MG; Srinivasan S
Inflamm Bowel Dis; 2013 Nov; 19(12):2535-46. PubMed ID: 24108115
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis.
Chandrasekharan B; Bala V; Kolachala VL; Vijay-Kumar M; Jones D; Gewirtz AT; Sitaraman SV; Srinivasan S
PLoS One; 2008 Oct; 3(10):e3304. PubMed ID: 18836554
[TBL] [Abstract][Full Text] [Related]
4. Glial-derived neurotrophic factor modulates enteric neuronal survival and proliferation through neuropeptide Y.
Anitha M; Chandrasekharan B; Salgado JR; Grouzmann E; Mwangi S; Sitaraman SV; Srinivasan S
Gastroenterology; 2006 Oct; 131(4):1164-78. PubMed ID: 17030186
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-449a deficiency promotes colon carcinogenesis.
Niki M; Nakajima K; Ishikawa D; Nishida J; Ishifune C; Tsukumo SI; Shimada M; Nagahiro S; Mitamura Y; Yasutomo K
Sci Rep; 2017 Sep; 7(1):10696. PubMed ID: 28878284
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.
Rigby RJ; Simmons JG; Greenhalgh CJ; Alexander WS; Lund PK
Oncogene; 2007 Jul; 26(33):4833-41. PubMed ID: 17297444
[TBL] [Abstract][Full Text] [Related]
7. Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation.
Shukla PK; Chaudhry KK; Mir H; Gangwar R; Yadav N; Manda B; Meena AS; Rao R
BMC Cancer; 2016 Mar; 16():189. PubMed ID: 26951793
[TBL] [Abstract][Full Text] [Related]
8. Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis.
Klompus M; Ho W; Sharkey KA; McKay DM
Regul Pept; 2010 Dec; 165(2-3):138-45. PubMed ID: 20561896
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer.
Velázquez KT; Enos RT; McClellan JL; Cranford TL; Chatzistamou I; Singh UP; Nagarkatti M; Nagarkatti PS; Fan D; Murphy EA
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G347-58. PubMed ID: 26744471
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
11. The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling.
Maoa R; Zou F; Yang L; Lin S; Li Y; Ma M; Yin P; Liang X; Liu J
Int J Biochem Cell Biol; 2015 Dec; 69():153-61. PubMed ID: 27022656
[TBL] [Abstract][Full Text] [Related]
12. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis.
Josse C; Bouznad N; Geurts P; Irrthum A; Huynh-Thu VA; Servais L; Hego A; Delvenne P; Bours V; Oury C
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G229-43. PubMed ID: 24464560
[TBL] [Abstract][Full Text] [Related]
13. The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.
Hyland NP; Cox HM
Br J Pharmacol; 2005 Nov; 146(5):712-22. PubMed ID: 16100526
[TBL] [Abstract][Full Text] [Related]
14. Role of milk fat globule-epidermal growth factor 8 in colonic inflammation and carcinogenesis.
Kusunoki R; Ishihara S; Tada Y; Oka A; Sonoyama H; Fukuba N; Oshima N; Moriyama I; Yuki T; Kawashima K; Ansary MM; Tajima Y; Maruyama R; Nabika T; Kinoshita Y
J Gastroenterol; 2015 Aug; 50(8):862-75. PubMed ID: 25596854
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
16. Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells.
Kang DW; Choi CY; Cho YH; Tian H; Di Paolo G; Choi KY; Min do S
J Exp Med; 2015 Jul; 212(8):1219-37. PubMed ID: 26122663
[TBL] [Abstract][Full Text] [Related]
17. Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.
Painsipp E; Herzog H; Sperk G; Holzer P
Br J Pharmacol; 2011 Jul; 163(6):1302-14. PubMed ID: 21410462
[TBL] [Abstract][Full Text] [Related]
18. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.
Bian Z; Li L; Cui J; Zhang H; Liu Y; Zhang CY; Zen K
J Pathol; 2011 Dec; 225(4):544-53. PubMed ID: 21590770
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses.
Hayakawa Y; Hirata Y; Nakagawa H; Sakamoto K; Hikiba Y; Otsuka M; Ijichi H; Ikenoue T; Tateishi K; Akanuma M; Ogura K; Yoshida H; Ichijo H; Omata M; Maeda S
Gastroenterology; 2010 Mar; 138(3):1055-67.e1-4. PubMed ID: 19931259
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]